FNY Investment Advisers’s Gilead Sciences GILD Stock Holding History

FNY Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,700	Closed	-$576K	–	904
2025 Q4	$576K	Buy	+4,700	New	+$571K	0.16%	128
2025 Q1	–	Sell	-5,100	Closed	-$471K	–	823
2024 Q4	$471K	Buy	+5,100	New	+$459K	0.24%	84
2024 Q1	–	Sell	-100	Closed	-$8K	–	733
2023 Q4	$8K	Buy	+100	New	+$7.78K	0.01%	325
2022 Q2	–	Sell	-35	Closed	-$2K	–	777
2022 Q1	$2K	Buy	+35	New	+$2.24K	﹤0.01%	619
2021 Q1	–	Sell	-50	Closed	-$2K	–	873
2020 Q4	$2K	Buy	+50	New	+$3.02K	﹤0.01%	698
2019 Q4	–	Sell	-86	Closed	-$5K	–	904
2019 Q3	$5K	Sell	86 -983	-92%	-$64.3K	﹤0.01%	646
2019 Q2	$72K	Buy	+1,069	New	+$70.3K	0.02%	321
2018 Q4	–	Sell	-549	Closed	-$42K	–	798
2018 Q3	$42K	Buy	+549	New	+$41.5K	0.01%	385

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

FNY Investment Advisers's GILD Position: Q1 2026 in Review

FNY Investment Advisers sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 4,700 shares — an estimated $576K sold.

FNY Investment Advisers first reported a position in GILD in Q3 2018 and held it in 8 quarters. The position peaked at $576K in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

FNY Investment Advisers reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
FNY Investment Advisers sold 4,700 Gilead Sciences shares in Q1 2026, an estimated $576K.
FNY Investment Advisers first reported a position in Gilead Sciences in Q3 2018 and held it in 8 quarters.
FNY Investment Advisers's Gilead Sciences position peaked at $576K in Q4 2025.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.